US equities |
INTC $92.07 ▲+0.00% SNDK $1,330.05 ▲+0.00% MU $934.27 ▲+0.00% NVDA $213.66 ▲+0.00% SKHY $162.09 ▲+0.00% GOOGL $283.82 ▲+0.00% AMZN $243.79 ▲+0.00% TSLA $403.30 ▲+0.00%
FinancialContent

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

9.560 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
24 25 Next >
News headline image
Kaplan Fox Announces an Investigation Into Iovance Biotherapeutics, Inc. (IOVA) for Potential Securities Law Violations
Via TheNewswire.com
News headline image
Securities Fraud Investigation Into Iovance Biotherapeutics, Inc. (IOVA) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
3 Monster Stocks in the Making ↗
Via The Motley Fool
News headline image
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Iovance Biotherapeutics’ (IOVA) Annual Maintenance: Assurances Collide with Adverse Disclosure as Shares Plunge 44% – Hagens Berman
From Hagens Berman
Via Business Wire
News headline image
Top movers in Friday's session ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
Securities Fraud Investigation Into Iovance Biotherapeutics, Inc. (IOVA) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Keep an eye on the top gainers and losers in Friday's session. ↗
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
The market is filled with gapping stocks in Friday's session. ↗
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Why Iovance Biotherapeutics Stock Is Crashing Today ↗
Via The Motley Fool
News headline image
Wondering what's happening in today's pre-market session? ↗
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Expert Outlook: Iovance Biotherapeutics Through The Eyes Of 9 Analysts ↗
 
Via Benzinga
News headline image
Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday ↗
 
Via Benzinga
News headline image
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Uncovering Potential: Iovance Biotherapeutics's Earnings Preview ↗
 
Via Benzinga
News headline image
My 3 Favorite Stocks to Buy Right Now ↗
There are plenty of good ones to choose from, but these three are all undervalued, leaving them ripe for a lot of bullishness sooner than later. 
Via The Motley Fool
News headline image
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
2 Beaten-Down Stocks With Incredible Upside Potential ↗
Via The Motley Fool
News headline image
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year. ↗
Via The Motley Fool
News headline image
This Biotech Stock Could Be the Best Investment of the Decade ↗
There's an incredible growth story hiding in plain sight for investors who can look to the future. 
Via The Motley Fool
News headline image
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
News headline image
Is Iovance Biotherapeutics a Millionaire-Maker? ↗
Via The Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
24 25 Next >